
David Hou Awarded 2022 ABTA Lucien Rubinstein Award for ‘B Cell Vaccine Promotes Anti-Glioma Immunity Through Modulating CD8+ T Cells’
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
Vince Rock answers the top questions he receives from patients and caregivers who call the ABTA CareLine.
As we welcome 2023, it’s a time to embrace the new year and new ways to get involved and make an impact in the brain tumor community.
Meet two researchers on opposite ends of the globe dedicated to transforming the future of brain tumor treatments.
**Sponsored Content**
Chris traveled across the country for a minimally invasive “keyhole” procedure to remove his large meningioma. Read why he chose Dr. Daniel Kelly at Pacific Neuroscience Institute (PNI) for his brain surgery.
Go behind the scenes of the nation’s largest brain tumor conference and hear why the co-chairs say you don’t want to miss this year’s event, Sept. 9-10!
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
**Sponsored Content**
See how Mary is defying the odds years after her initial glioblastoma diagnosis and how she found peace of mind through GammaTile Therapy, a one-time, targeted radiation treatment.
The need for better brain tumor treatments is greater than ever. That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.
The ABTA has been a top resource for brain tumor educational materials for over 50 years. All of our educational brochures are carefully reviewed by brain tumor medical experts, and brain tumor patients and caregivers.. These brochures are 100% free for patients and caregivers.
Donating to the ABTA is a meaningful way to recognize someone whose life has been impacted by a brain tumor. With your gift, you can honor key milestones in a brain tumor survivor’s life, or convey the sense of loss when a friend or loved one loses their battle with this disease.